-+ 0.00%
-+ 0.00%
-+ 0.00%

2seventy bio Q4 2024 GAAP EPS $(0.37) Misses $(0.24) Estimate, Sales $2.926 Miss $12.293M Estimate

Benzinga·03/25/2025 20:11:49
Listen to the news
2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24) by 54.17 percent. This is a 66.67 percent increase over losses of $(1.11) per share from the same period last year. The company reported quarterly sales of $2.926 which missed the analyst consensus estimate of $12.293 million by 100.00 percent. This is a 100.00 percent decrease over sales of $10.684 million the same period last year.